Breaking News
Get 40% Off 0
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list
Close

Aptorum Group Ltd Class A (APM)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Aptorum A's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
7.250 -0.400    -5.23%
17/04 - Closed. Currency in USD ( Disclaimer )
Pre Market
6.920
-0.330
-4.552%
8:41:53 - Real-time Data
Type:  Equity
Market:  United States
  • Volume: 75,518
  • Bid/Ask: 6.800 / 7.040
  • Day's Range: 7.050 - 7.620
Aptorum A 7.250 -0.400 -5.23%

Aptorum Group Ltd Class A Company Profile

 
Get an in-depth profile of Aptorum Group Ltd Class A, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryPharmaceuticals
SectorHealthcare
Employees

19

Equity Type

ORD

Aptorum Group Limited, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products for the treatment of infectious diseases and cancer. The company operates in the Therapeutics and Non-Therapeutics segments. Its pipeline products include SACT- 1 for neuroblastoma and other cancer types; SACT-COV19 for the treatment of coronavirus disease; ALS-4 to treat bacterial infections caused by staphylococcus aureus, including MRSA; and ALS-1 to treat viral infections caused by influenza virus A. The company is also developing ALS-2/3 for the treatment of gram+ve bacterial infections; RPIDD, a pathogen molecular diagnostic; NativusWell DOI (NLS-2), a dietary supplement; NLS-1 for the treatment of endometriosis; DLS-1+2 to treat NSCLC with mutation; DLS-3, an autoimmune small molecule; and CLS-1 for the treatment of obesity. Its pipeline products enable the discovery of new therapeutics assets, such as systematic screening of existing approved drug molecules, and microbiome-based research platforms for treatment of metabolic diseases. The company also focuses on therapeutic and diagnostic projects in neurology, gastroenterology, metabolic disorders, women's health, and other disease areas. In addition, it operates a medical clinic. The company was formerly known as APTUS Holdings Limited and changed its name to Aptorum Group Limited in October 2017. Aptorum Group Limited was incorporated in 2010 and is headquartered in London, the United Kingdom. Aptorum Group Limited is a subsidiary of Jurchen Investment Corporation.

Contact Information

Address 17 Hanover Square
London, W1S 1BN
United Kingdom
Phone 44 20 8092 9299
Fax 44 20 3928 8277

Top Executives

Name Age Since Title
Mirko Scherer 54 2017 Independent Non-Executive Director
Chung Yuen Huen 43 2023 Founder, CEO & Non-Executive Director
Kwei-Hang Chan 76 2018 Member of Scientific Advisory Board
William J. Weiss - 2020 Member of Scientific Advisory Board
Francis Szele - 2020 Member of Scientific Advisory Board
Charles Bathurst 67 2017 Independent Non-Executive Director
Justin Wu 52 2017 Independent Non-Executive Director
Lawrence Baum - 2020 Member of Scientific Advisory Board
Douglas W. Arner 53 2018 Independent Non-Executive Director
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

APM Comments

Write your thoughts about Aptorum Group Ltd Class A
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
L VIB
L VIB Mar 06, 2024 2:21PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
sazzzz...would like to know which stock will rise up like this...
MIKHAIL KUZNETSOV
MIKHAIL KUZNETSOV Jan 30, 2022 12:44PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Added by 1,75. I waiting a new rally to the 3 and more…
Şarapçı Hayri
Şarapçı Hayri Jan 25, 2022 5:01AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
%86 premarket? another meme stock?
Farry Hardianto
Farry Hardianto Sep 30, 2020 1:57AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Sometimes need to risk 6 in order to get 3. Not sure if it's healthy.
Bebo Saad
Bebo Saad Sep 29, 2020 1:19PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
good bye enjoy your day
Bebo Saad
Bebo Saad Sep 29, 2020 1:00PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
captain start flying again
Mr MARKET
Mr MARKET Sep 29, 2020 12:57PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Captain --- Cabincrew get ready for Landing
Bebo Saad
Bebo Saad Sep 29, 2020 11:57AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
guys are you think this will spike more
Henri Oskar
Henri Oskar Sep 29, 2020 11:57AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Yes
Muhammad Naveed
Muhammad Naveed Sep 29, 2020 11:57AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
If you are in loss cut your losses before its too late.
대환 임
대환 임 Sep 29, 2020 11:09AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Im trying to say i am ok..... it will be alright.
대환 임
대환 임 Sep 29, 2020 11:05AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Oh ye~
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email